Clinical Trials Directory

Trials / Completed

CompletedNCT00885586

Acupuncture in Herpes Zoster Neuralgia (ACUZoster)

Analgetic Effectiveness of Acupuncture When Compared to a Standardised Analgesic Regimen in the Treatment of Herpes Zoster Neuralgia

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
68 (actual)
Sponsor
Dominik Irnich · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Symptoms that herald herpes zoster include pruritus, dysesthesia and pain along the distribution of the involved dermatome. The most distressing symptom is typically pain and the most feared complication is postherpetic neuralgia (PHN), the persistence of pain long after rash healing. PHN is defined as pain persisting more than 3 months after the rash has healed. Both, the acute pain associated with herpes zoster and the chronic pain of PHN, have multiple adverse effects on health-related quality of life. The primary objective of the trial presented is to investigate whether a 4 week semi-standardised acupuncture is non-inferior (first step) or superior (second step) to (a) the anticonvulsive drug gabapentin and (b) sham laser acupuncture in the treatment of pain associated with herpes zoster in addition to standardised analgesics. Secondary objectives include an assessment of the change of sensoric function, of long-term effectiveness, the occurrence of PHN and an evaluation of several pain specific questionnaires

Conditions

Interventions

TypeNameDescription
DEVICESham-laser acupunctureLaser irradiation is faked, approaching a non-functioning laser pen.
DRUGgabapentinePatients in this arm are treated individually with gabapentine 900 mg/d - 3600 mg/d, according to the recommended scheme given by the manufacturer
PROCEDUREAcupunctureThe needle acupuncture technique used in this trial is performed according the traditional way (TCM) using expendable needles.

Timeline

Start date
2008-11-01
Primary completion
2017-08-29
Completion
2018-04-05
First posted
2009-04-22
Last updated
2018-08-10

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00885586. Inclusion in this directory is not an endorsement.